Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 1, 1996
In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisN Rastogi, K S Goh, A Bryskier, et al.The Journal of Antimicrobial Chemotherapy|October 6, 2000
Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCGN Rastogi, K S Goh, M Berchel, et al.Antimicrobial Agents and Chemotherapy|April 19, 2000
In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensisJ M Rolain, M Maurin, A Bryskier, et al.Chemotherapy|January 1, 1986
Study of the diffusion of cefmenoxime into the bronchial secretionsC Serieys, E Bergogne-Berezin, H Kafe, et al.Antimicrobial Agents and Chemotherapy|August 4, 1998
Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophilsD Vazifeh, A Preira, A Bryskier, et al.Annales De Biologie Clinique|January 1, 1981
[Role of Clostridium and its toxin in pseudo-membranous colitis (author's transl)]A Bryskier, J Doll, M T Labro, et al.Antimicrobial Agents and Chemotherapy|June 20, 2000
Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmasC M Bebear, H Renaudin, A Bryskier, et al.Pathologie-Biologie|May 1, 1983
[In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam]M O Husson, A Bryskier, D Izard, et al.Drugs Under Experimental and Clinical Research|January 1, 1985
Behaviour of cefmenoxime towards beta-lactamasesR Labia, A Morand, H Ben Yaghlane, et al.Pageof 12